Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery (Q37978509)

26 August 2017

Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery (English)

1 reference

26 August 2017

Lauren Willis

1

1 reference

PubMed ID

22274758

26 August 2017

Don Hayes

series ordinal

2

1 reference

PubMed ID

22274758

26 August 2017

Heidi M Mansour

series ordinal

3

1 reference

26 August 2017

25 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

190

1 reference

26 August 2017

251-262

1 reference

26 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00408-011-9360-x

26 August 2017

0 references

cites work

Nanomedicine in pulmonary delivery

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Inhaling medicines: delivering drugs to the body through the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Formation, characterization, and fate of inhaled drug nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Pulmonary targeting of nanoparticle drug matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Inhalable liposomal formulation for vasoactive intestinal peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Liposomal dry powders as aerosols for pulmonary delivery of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Nanoparticle formulations in pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Micro- and nanocarrier-mediated lung targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Characterization of the in situ structural and interfacial properties of the cationic hydrophobic heteropolypeptide, KL4, in lung surfactant bilayer and monolayer models at the air-water interface: implications for pulmonary surfactant delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Enhanced anti-inflammation of inhaled dexamethasone palmitate using mannosylated liposomes in an endotoxin-induced lung inflammation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

The lungs as a portal of entry for systemic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Evaluation of antitubercular drug-loaded surfactants as inhalable drug-delivery systems for pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Budesonide/formoterol combination in COPD: a US perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Development of liposomal salbutamol sulfate dry powder inhaler formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Dry powder inhalation of liposomal Ketotifen fumarate: formulation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Liposomal aerosols in the management of pulmonary infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Liposome-based drug delivery to alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Development of liposomal amphotericin B dry powder inhaler formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Differential behaviour of fluid liposomes toward mammalian epithelial cells and bacteria: restriction of fusion to bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Pharmacokinetic and pharmacodynamic evaluation of liposomal amikacin for inhalation in cystic fibrosis patients with chronic pseudomonal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

An alternative aerosol delivery system for amiloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Nano-liposomal dry powder inhaler of Amiloride Hydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Development of spray dried liposomal dry powder inhaler of Dapsone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Immunosuppressive therapy after human lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

CHARACTERIZATION AND ADMINISTRATION OF CYCLOSPORINE LIPOSOMES AS A SMALL-PARTICLE AEROSOL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

21 January 2018

Aerosolized chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Liposomes as drug carriers in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Formulations for pulmonary administration of anticancer agents to treat lung malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Inhalable microparticles containing large payload of anti-tuberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

In vitro evaluation of inhalable isoniazid-loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Monitoring safety of liposomes containing rifampicin on respiratory cell lines and in vitro efficacy against Mycobacterium bovis in alveolar macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Nanomedicine for respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00408-011-9360-X

Aerosol delivery of liposomal all-trans-retinoic acid to the lungs

21 January 2018

1 reference

12 December 2020

Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics

1 reference

12 December 2020

Cyclosporin A enhances paclitaxel toxicity against leukemia and respiratory epithelial cancers.

1 reference

12 December 2020

Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung

1 reference

12 December 2020

Deaths: final data for 2007.

1 reference

12 December 2020

No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes

1 reference

12 December 2020

Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model

1 reference

12 December 2020

Chitosan-coated antifungal formulations for nebulisation

1 reference

12 December 2020

Relationships between equilibrium spreading pressure and phase equilibria of phospholipid bilayers and monolayers at the air-water interface

1 reference

12 December 2020

Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice

1 reference

12 December 2020

Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung

1 reference

12 December 2020

9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice

1 reference

12 December 2020

Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy

1 reference

12 December 2020

The relationship between water vapor absorption and desorption by phospholipids and bilayer phase transitions

1 reference

12 December 2020

Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder

1 reference

12 December 2020

Pulmonary disposition of budesonide from liposomal dry powder inhaler.

1 reference

12 December 2020

Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers

1 reference

12 December 2020

Pulmonary effects of chronic exposure to liposome aerosols in mice

1 reference

12 December 2020

Recent advances in liposomal dry powder formulations: preparation and evaluation

1 reference

12 December 2020

Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis

1 reference

12 December 2020

Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice

1 reference

12 December 2020

Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes

1 reference

12 December 2020

Lung deposition of a liposomal cyclosporine A inhalation solution in patients after lung transplantation.

1 reference

12 December 2020

Effect of phospholipid composition on characterization of liposomes containing 9-nitrocamptothecin

1 reference

12 December 2020

10.1007/S00408-011-9360-X

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22274758